{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:08:37Z","timestamp":1791212917550,"version":"4.1.0"},"reference-count":31,"publisher":"American Society of Hematology","issue":"26","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,6,26]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>Trisomy 12 CLL cells exhibit upregulated integrin signaling and enhanced VLA-4-directed adhesion and motility. The increased expression of \u03b22-integrins on trisomy 12 CLL cells is modulated by intercurrent NOTCH1 mutations.<\/jats:p>","DOI":"10.1182\/blood-2014-01-552307","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T09:11:34Z","timestamp":1400145094000},"page":"4101-4110","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":66,"title":["Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations"],"prefix":"10.1182","volume":"123","author":[{"given":"John C.","family":"Riches","sequence":"first","affiliation":[{"name":"Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor J.","family":"O\u2019Donovan","sequence":"additional","affiliation":[{"name":"Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Kingdon","sequence":"additional","affiliation":[{"name":"Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"McClanahan","sequence":"additional","affiliation":[{"name":"Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Clear","sequence":"additional","affiliation":[{"name":"Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna S.","family":"Neuberg","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Werner","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo M.","family":"Croce","sequence":"additional","affiliation":[{"name":"Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University Wexner Medical Center, Columbus, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan G.","family":"Ramsay","sequence":"additional","affiliation":[{"name":"Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Z.","family":"Rassenti","sequence":"additional","affiliation":[{"name":"Moores Cancer Center, University of California, San Diego, La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Kipps","sequence":"additional","affiliation":[{"name":"Moores Cancer Center, University of California, San Diego, La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Gribben","sequence":"additional","affiliation":[{"name":"Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2019111818385756000_B1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1182\/blood-2011-10-386144","article-title":"NOTCH1 mutations in CLL associated with trisomy 12.","volume":"119","author":"Balatti","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2019111818385756000_B2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.V82.2.571.571","article-title":"Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology.","volume":"82","author":"Que","year":"1993","journal-title":"Blood"},{"issue":"5","key":"2019111818385756000_B3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/PPO.0b013e31826cda2d","article-title":"Small lymphocytic lymphoma and chronic lymphocytic leukemia: are they the same disease?","volume":"18","author":"Santos","year":"2012","journal-title":"Cancer J"},{"issue":"15","key":"2019111818385756000_B4","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood-2013-03-489518","article-title":"Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.","volume":"122","author":"Chigrinova","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2019111818385756000_B5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2141.1998.00661.x","article-title":"Trisomy 12 is seen within a specific subtype of B-cell chronic lymphoproliferative disease affecting the peripheral blood\/bone marrow and co-segregates with elevated expression of CD11a.","volume":"101","author":"Su\u2019ut","year":"1998","journal-title":"Br J Haematol"},{"issue":"19","key":"2019111818385756000_B6","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/blood-2013-06-507335","article-title":"CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism.","volume":"122","author":"Zucchetto","year":"2013","journal-title":"Blood"},{"issue":"12","key":"2019111818385756000_B7","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1182\/blood-2009-06-228981","article-title":"The lymphatic tissue microenvironments in chronic lymphocytic leukemia: in vitro models and the significance of CD40-CD154 interactions.","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"issue":"31","key":"2019111818385756000_B8","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1200\/JCO.2006.06.4642","article-title":"Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome.","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"issue":"21","key":"2019111818385756000_B9","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2012.44.2137","article-title":"Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation.","volume":"31","author":"Kiaii","year":"2013","journal-title":"J Clin Oncol"},{"issue":"9","key":"2019111818385756000_B10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nri2156","article-title":"Getting to the site of inflammation: the leukocyte adhesion cascade updated.","volume":"7","author":"Ley","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2019111818385756000_B11","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood-2007-05-092486","article-title":"Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.","volume":"111","author":"Gattei","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111818385756000_B12","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4049\/jimmunol.160.1.395","article-title":"Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member.","volume":"160","author":"Deaglio","year":"1998","journal-title":"J Immunol"},{"issue":"2","key":"2019111818385756000_B13","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1006\/bbrc.1994.2326","article-title":"Cell surface antigen CD38 identified as ecto-enzyme of NAD glycohydrolase has hyaluronate-binding activity.","volume":"203","author":"Nishina","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2019111818385756000_B14","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"issue":"1-2","key":"2019111818385756000_B15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/10428190109097682","article-title":"CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.","volume":"42","author":"D\u2019Arena","year":"2001","journal-title":"Leuk Lymphoma"},{"issue":"18","key":"2019111818385756000_B16","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMoa023143","article-title":"ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.","volume":"348","author":"Crespo","year":"2003","journal-title":"N Engl J Med"},{"issue":"9","key":"2019111818385756000_B17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa040857","article-title":"ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.","volume":"351","author":"Rassenti","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111818385756000_B18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nm.1921","article-title":"Kindlin-3 is required for beta2 integrin-mediated leukocyte adhesion to endothelial cells.","volume":"15","author":"Moser","year":"2009","journal-title":"Nat Med"},{"issue":"26","key":"2019111818385756000_B19","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia.","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111818385756000_B20","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/leu.2011.369","article-title":"The CD49d\/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.","volume":"26","author":"Zucchetto","year":"2012","journal-title":"Leukemia"},{"issue":"2","key":"2019111818385756000_B21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2141.2011.08725.x","article-title":"Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9.","volume":"154","author":"Buggins","year":"2011","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111818385756000_B22","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/leu.2013.319","article-title":"Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia.","volume":"28","author":"Arruga","year":"2014","journal-title":"Leukemia"},{"issue":"9","key":"2019111818385756000_B23","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1002\/1521-4141(200009)30:9<2465::AID-IMMU2465>3.0.CO;2-0","article-title":"c-Myc inhibits CD11a and CD11c leukocyte integrin promoters.","volume":"30","author":"L\u00f3pez-Rodr\u00edguez","year":"2000","journal-title":"Eur J Immunol"},{"issue":"8","key":"2019111818385756000_B24","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V99.8.2977","article-title":"The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes.","volume":"99","author":"Till","year":"2002","journal-title":"Blood"},{"issue":"8","key":"2019111818385756000_B25","doi-asserted-by":"crossref","first-page":"e23758","DOI":"10.1371\/journal.pone.0023758","article-title":"Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.","volume":"6","author":"Brachtl","year":"2011","journal-title":"PLoS ONE"},{"issue":"12","key":"2019111818385756000_B26","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1182\/blood-2004-10-4054","article-title":"CLL, but not normal, B cells are dependent on autocrine VEGF and alpha4beta1 integrin for chemokine-induced motility on and through endothelium.","volume":"105","author":"Till","year":"2005","journal-title":"Blood"},{"issue":"7","key":"2019111818385756000_B27","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1158\/0008-5472.CAN-08-4136","article-title":"Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.","volume":"69","author":"Hartmann","year":"2009","journal-title":"Cancer Res"},{"key":"2019111818385756000_B28","doi-asserted-by":"crossref","DOI":"10.1007\/s00277-013-1967-y","article-title":"The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.","author":"Brachtl","year":"2014","journal-title":"Ann Hematol"},{"key":"2019111818385756000_B29","article-title":"Characterization of a novel in vitro circulation system designed to model the migration of primary CLL cells across the vascular endothelium.","volume":"122 [Abstract 667]","author":"Walsby","year":"2013","journal-title":"Blood"},{"issue":"3","key":"2019111818385756000_B30","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.4049\/jimmunol.1203484","article-title":"Chemokine unresponsiveness of chronic lymphocytic leukemia cells results from impaired endosomal recycling of Rap1 and is associated with a distinctive type of immunological anergy.","volume":"191","author":"Pye","year":"2013","journal-title":"J Immunol"},{"issue":"20","key":"2019111818385756000_B31","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1158\/0008-5472.CAN-08-1758","article-title":"Cell motility in chronic lymphocytic leukemia: defective Rap1 and alphaLbeta2 activation by chemokine.","volume":"68","author":"Till","year":"2008","journal-title":"Cancer Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/26\/4101\/1378551\/4101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/26\/4101\/1378551\/4101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T04:26:16Z","timestamp":1689222376000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/123\/26\/4101\/32798\/Trisomy-12-chronic-lymphocytic-leukemia-cells"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,26]]},"references-count":31,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2014,6,26]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2014-01-552307","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,26]]}}}